<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">vedomostiregmed</journal-id><journal-title-group><journal-title xml:lang="ru">Регуляторные исследования и экспертиза лекарственных средств</journal-title><trans-title-group xml:lang="en"><trans-title>Regulatory Research and Medicine Evaluation</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">3034-3062</issn><issn pub-type="epub">3034-3453</issn><publisher><publisher-name>Federal State Budgetary Institution ‘Scientific Centre for Expert Evaluation of Medicinal Products’ of the Ministry of Health of the Russian Federation (FSBI ‘SCEEMP’)</publisher-name></publisher></journal-meta><article-meta><article-id custom-type="elpub" pub-id-type="custom">vedomostiregmed-130</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>ОБЗОРНЫЕ И ПРОБЛЕМНЫЕ СТАТЬИ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>GENERAL AND TOPICAL ARTICLES</subject></subj-group></article-categories><title-group><article-title>Применение информационных технологий для управления фармацевтическими данными</article-title><trans-title-group xml:lang="en"><trans-title>Information technologies as a tool of pharmaceutical data management</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Кошечкин</surname><given-names>К. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Koshechkin</surname><given-names>K. A.</given-names></name></name-alternatives><email xlink:type="simple">noemail@neicon.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0009-0008-5452-9758</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Рычихина</surname><given-names>Е. М.</given-names></name><name name-style="western" xml:lang="en"><surname>Rychikhina</surname><given-names>E. M.</given-names></name></name-alternatives><email xlink:type="simple">noemail@neicon.ru</email><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>Научный центр экспертизы средств медицинского применения</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Scientific Centre for Expert Evaluation of Medicinal Products</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2017</year></pub-date><pub-date pub-type="epub"><day>13</day><month>02</month><year>2018</year></pub-date><volume>7</volume><issue>2</issue><fpage>122</fpage><lpage>125</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Кошечкин К.А., Рычихина Е.М., 2018</copyright-statement><copyright-year>2018</copyright-year><copyright-holder xml:lang="ru">Кошечкин К.А., Рычихина Е.М.</copyright-holder><copyright-holder xml:lang="en">Koshechkin K.A., Rychikhina E.M.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.vedomostincesmp.ru/jour/article/view/130">https://www.vedomostincesmp.ru/jour/article/view/130</self-uri><abstract><p>Подготовлен обзор международного опыта применения информационных технологий для управления фармацевтическими данными. Изучена возможность внедрения CALS/PLM-технологий для информатизации фармации на примере внедрения формата регистрационного досье eCTD. Рекомендованы направления работы по переходу на аналогичный формат в рамках работы регуляторных органов Российской Федерации и применению его для формирования единого рынка лекарственных средств Евразийского экономического союза. Приведена краткая характеристика модулей, входящих в общий технический документ, и их наполнение, а также общие принципы создания электронной версии согласно данному формату. Применение единого электронного формата предоставления досье позволит автоматизировать контроль за полнотой направляемых документов, интегрировать информационные системы разработчиков лекарственных препаратов и регуляторных органов.</p></abstract><trans-abstract xml:lang="en"><p>The article analyses international experience of information technology use in pharmaceutical data management. It investigates the possibility of using CALS/PLM-technologies for IT-based management of pharmacy-related activities as exemplified by the introduction of the eCTD format of the registration dossier. The authors provide recommendations that could facilitate the Russian regulatory system’s transition to a similar format and help use this format to create the common medicines market within the Eurasian Economic Union. A brief description of the modules included in the common technical document and their content is provided, as well as general principles of developing an electronic version of the present format. The use of a single electronic format for dossier submission will make it possible to automatically control the completeness of submitted materials and to integrate information systems used by manufactures and regulatory authorities.</p></trans-abstract><kwd-group xml:lang="ru"><kwd>регистрационное досье</kwd><kwd>CTD</kwd><kwd>eCTD</kwd><kwd>ОТД</kwd><kwd>информатизация фармации</kwd><kwd>CALS/PLM-технологии</kwd><kwd>registration dossier</kwd><kwd>CTD</kwd><kwd>eCTD</kwd><kwd>computerisation of pharmacy-related activities</kwd><kwd>CALS/PLM-technologies</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Договор о Евразийском экономическом союзе, Астана, 29 мая 2014 года. Available from: https://goo.gl/lKMyOl.</mixed-citation><mixed-citation xml:lang="en">Treaty on the Eurasian Economic Union, Astana, May 29, 2014. Available from: https://goo.gl/lKMyOl (in Russian).</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Правила регистрации и экспертизы лекарственных средств для медицинского применения. Проект. Available from: https://goo.gl/ 1Uo9T5.</mixed-citation><mixed-citation xml:lang="en">Draft rules for registration and analysis of medical products for human use. Available from: https://goo.gl/1Uo9T5 (in Russian).</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Guidance for Industry, ICH M4. Organization of the CTD. U. S. Department of Health and Human Services Food and Drug Administration. Center for Drug Evaluation and Research (CDER). Center for Biologics Evaluation and Research (CBER). August 2001.</mixed-citation><mixed-citation xml:lang="en">Guidance for Industry, ICH M4. Organization of the CTD. U. S. Department of  Health and Human Services Food and Drug Administration. Center for Drug Evaluation  and Research (CDER). Center for Biologics Evaluation and Research (CBER). August 2001.</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Бунятян НД, Сакаева ИВ, Косарева ТВ, Корсун ЛВ, Саканян ВА. Сравнительная характеристика системы регистрации лекарственных препаратов в Российской Федерации и странах Европейского Союза. Ведомости Научного центра экспертизы средств медицинского применения 2011; (2): 39-42.</mixed-citation><mixed-citation xml:lang="en">Bunyatyan ND, Sakaeva IV, Kosareva TV, Korsun LV, Sakanyan VA. Comparative  analysis of drug registration system in the Russian Federation and in the European  Union. The Bulletin of the Scientific Centre for Expert Evaluation of Medicinal  Products 2011; (2): 39–42 (in Russian).</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">U. S. FDA Signals Intent to Reject eCTDs with Technical Issues. Available from: https://goo.gl/7sstwY.</mixed-citation><mixed-citation xml:lang="en">U. S. FDA Signals Intent to Reject eCTDs with Technical Issues. Available from: https://goo.gl/7sstwY.</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Clark K. Updates from the Regulators: FDA. Available from: https:// goo.gl/zdiHUQ.</mixed-citation><mixed-citation xml:lang="en">Clark K. Updates from the Regulators: FDA. Available from: https://goo.gl/zdiHUQ.</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Clark K. DIA Update: News from the FDA. Available from: https:// goo.gl/hN45JN.</mixed-citation><mixed-citation xml:lang="en">Clark K. DIA Update: News from the FDA. Available from: https://goo.gl/hN45JN.</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Федеральный закон Российской Федерации от 22 декабря 2014 г. № 429-ФЗ «О внесении изменений в Федеральный закон «Об обращении лекарственных средств». Available from: https://goo.gl/VOzDjU.</mixed-citation><mixed-citation xml:lang="en">Federal Law of the Russian Federation of 22.12.2014 No. 429-FZ «On Amending the Federal Law «On Circulation of Medicines» (in Russian).</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Меркулов ВА, Бунятян НД, Кошечкин КА, Сбоев ГА. Современное состояние и перспективы развития единого информационного пространства ФГБУ «НЦЭСМП» Минздрава России. Ведомости Научного центра экспертизы средств медицинского применения 2013; (4): 38-41.</mixed-citation><mixed-citation xml:lang="en">Available from: https://goo.gl/VOzDjU (in Russian).</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Merkulov VA, Bunyatyan ND, Koshechkin KA, Sboev GA. Current status and future  development of the single information space of the FSBI «SCEMAP» of the Ministry of  Health of the Russian Federation. The Bulletin of the Scientific Centre for Expert  Evaluation of Medicinal Products 2013; (4): 38–41 (in Russian).</mixed-citation><mixed-citation xml:lang="en">Merkulov VA, Bunyatyan ND, Koshechkin KA, Sboev GA. Current status and future  development of the single information space of the FSBI «SCEMAP» of the Ministry of  Health of the Russian Federation. The Bulletin of the Scientific Centre for Expert  Evaluation of Medicinal Products 2013; (4): 38–41 (in Russian).</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
